Leissring MA - Search Results

1

Aβ-Degrading Proteases: Therapeutic Potential in Alzheimer Disease.

Leissring MA. Leissring MA. CNS Drugs. 2016 Aug;30(8):667-75. doi: 10.1007/s40263-016-0364-1. CNS Drugs. 2016. PMID: 27349988 Free PMC article. Review.

2

Herpes simplex virus infections and Alzheimer's disease. Implications for drug treatment and immunotherapy.

Leissring MA, Sugarman MC, LaFerla FM. Leissring MA, et al. Drugs Aging. 1998 Sep;13(3):193-8. doi: 10.2165/00002512-199813030-00002. Drugs Aging. 1998. PMID: 9789723 Review.

3

Proteolytic degradation of the amyloid beta-protein: the forgotten side of Alzheimer's disease.

Leissring MA. Leissring MA. Curr Alzheimer Res. 2006 Dec;3(5):431-5. doi: 10.2174/156720506779025206. Curr Alzheimer Res. 2006. PMID: 17168642 Review.

4

The AbetaCs of Abeta-cleaving proteases.

Leissring MA. Leissring MA. J Biol Chem. 2008 Oct 31;283(44):29645-9. doi: 10.1074/jbc.R800022200. Epub 2008 Aug 22. J Biol Chem. 2008. PMID: 18723506 Free PMC article. Review.

5

Cathepsin D regulates cerebral Aβ42/40 ratios via differential degradation of Aβ42 and Aβ40.

Suire CN, Abdul-Hay SO, Sahara T, Kang D, Brizuela MK, Saftig P, Dickson DW, Rosenberry TL, Leissring MA. Suire CN, et al. Among authors: leissring ma. Alzheimers Res Ther. 2020 Jul 6;12(1):80. doi: 10.1186/s13195-020-00649-8. Alzheimers Res Ther. 2020. PMID: 32631408 Free PMC article.

6

Presenilin-1 immunoreactivity is localized intracellularly in Alzheimer's disease brain, but not detected in amyloid plaques.

Weber LL, Leissring MA, Yang AJ, Glabe CG, Cribbs DH, LaFerla FM. Weber LL, et al. Among authors: leissring ma. Exp Neurol. 1997 Jan;143(1):37-44. doi: 10.1006/exnr.1996.6348. Exp Neurol. 1997. PMID: 9000444

7

Characterization of insulin degrading enzyme and other amyloid-β degrading proteases in human serum: a role in Alzheimer's disease?

Liu Z, Zhu H, Fang GG, Walsh K, Mwamburi M, Wolozin B, Abdul-Hay SO, Ikezu T, Leissring MA, Qiu WQ. Liu Z, et al. Among authors: leissring ma. J Alzheimers Dis. 2012;29(2):329-40. doi: 10.3233/JAD-2011-111472. J Alzheimers Dis. 2012. PMID: 22232014 Free PMC article.

8

Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones.

Maianti JP, McFedries A, Foda ZH, Kleiner RE, Du XQ, Leissring MA, Tang WJ, Charron MJ, Seeliger MA, Saghatelian A, Liu DR. Maianti JP, et al. Among authors: leissring ma. Nature. 2014 Jul 3;511(7507):94-8. doi: 10.1038/nature13297. Epub 2014 May 21. Nature. 2014. PMID: 24847884 Free PMC article.

9

Selective Targeting of Extracellular Insulin-Degrading Enzyme by Quasi-Irreversible Thiol-Modifying Inhibitors.

Abdul-Hay SO, Bannister TD, Wang H, Cameron MD, Caulfield TR, Masson A, Bertrand J, Howard EA, McGuire MP, Crisafulli U, Rosenberry TR, Topper CL, Thompson CR, Schürer SC, Madoux F, Hodder P, Leissring MA. Abdul-Hay SO, et al. Among authors: leissring ma. ACS Chem Biol. 2015 Dec 18;10(12):2716-24. doi: 10.1021/acschembio.5b00334. Epub 2015 Sep 30. ACS Chem Biol. 2015. PMID: 26398879 Free PMC article.

10

Inhibition of Insulin-Degrading Enzyme Does Not Increase Islet Amyloid Deposition in Vitro.

Hogan MF, Meier DT, Zraika S, Templin AT, Mellati M, Hull RL, Leissring MA, Kahn SE. Hogan MF, et al. Among authors: leissring ma. Endocrinology. 2016 Sep;157(9):3462-8. doi: 10.1210/en.2016-1410. Epub 2016 Jul 12. Endocrinology. 2016. PMID: 27404391 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page